SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E Saland, H Boutzen, R Castellano, L Pouyet, E Griessinger, C Larrue, F de Toni, S Scotland, M David, G Danet-Desnoyers, F Vergez, Y Barreira, Y Collette, C Récher, J-E Sarry, A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia, Blood Cancer Journal, 2015, 5, 3, e297

    CrossRef

  2. 2
    Christoph Sippel, Young Kim, Anja Wallau, Peter Brossart, Ingo Schmidt-Wolf, Peter Walger, AML versus ICU: outcome of septic AML patients in an intensive care setting, Journal of Cancer Research and Clinical Oncology, 2015,

    CrossRef

  3. 3
    Rashmi Shivani Goswami, Cynthia S. Liang, Carlos E. Bueso-Ramos, Shimin Hu, Maitrayee Goswami, C. Cameron Yin, Gary Lu, L. Jeffrey Medeiros, Guilin Tang, Isolated +15 in bone marrow: Disease-associated or a benign finding?, Leukemia Research, 2015, 39, 1, 72

    CrossRef

  4. 4
    Magdalena Czemerska, Agnieszka Pluta, Anna Szmigielska-Kaplon, Ewa Wawrzyniak, Barbara Cebula-Obrzut, Aleksandra Medra, Piotr Smolewski, Tadeusz Robak, Agnieszka Wierzbowska, Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia, Leukemia & Lymphoma, 2015, 56, 2, 401

    CrossRef

  5. 5
    Jose F. Falantes, Pablo Trujillo, Jose I. Piruat, Cristina Calderón, Francisco J. Márquez-Malaver, Beatriz Martín-Antonio, Africa Millán, Marina Gómez, Jose González, Maria L. Martino, Isabel Montero, Rocío Parody, Ildefonso Espigado, Alvaro Urbano-Ispizua, Jose A. Pérez-Simón, Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia, Clinical Lymphoma Myeloma and Leukemia, 2015, 15, 4, 236

    CrossRef

  6. 6
    Anna Skwarska, Ewa Augustin, Michał Beffinger, Anita Wojtczyk, Sonia Konicz, Katarzyna Laskowska, Joanna Polewska, Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells, Biochemical Pharmacology, 2015, 95, 4, 238

    CrossRef

  7. 7
    L. Bolkun, D. Lemancewicz, E. Jablonska, A. Szumowska, U. Bolkun-Skornicka, W. Ratajczak-Wrona, J. Dzieciol, J. Kloczko, The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features, Annals of Hematology, 2015, 94, 1, 35

    CrossRef

  8. 8
    Latha Ramireddy, Chien-Yu Lin, Su-Ching Liu, Wan-Yu Lo, Rouh-Mei Hu, Yi-Chin Peng, Ching-Tien Peng, Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan, Cell Biochemistry and Biophysics, 2014, 70, 2, 1159

    CrossRef

  9. 9
    Anne S. Roug, Marcus C. Hansen, Line Nederby, Peter Hokland, Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age, British Journal of Haematology, 2014, 167, 2
  10. 10
    M. Bots, I. Verbrugge, B. P. Martin, J. M. Salmon, M. Ghisi, A. Baker, K. Stanley, J. Shortt, G. J. Ossenkoppele, J. Zuber, A. R. Rappaport, P. Atadja, S. W. Lowe, R. W. Johnstone, Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors, Blood, 2014, 123, 9, 1341

    CrossRef

  11. 11
    Kamila Kruczkowska-Tarantowicz, Klaudia Grądzka, Marzenna B. Klimiuk, Izabela Łapuć, Janusz Kłoczko, Długotrwała odpowiedź na leczenie azacytydyną pacjentki z ostrą białaczką szpikową z niekorzystnym profilem cytogenetycznym – prezentacja przypadku, Acta Haematologica Polonica, 2014, 45, 1, 93

    CrossRef

  12. 12
    Håkon Reikvam, Annette K Brenner, Ina Nepstad, André Sulen, Øystein Bruserud, Heat shock protein 70 – the next chaperone to target in the treatment of human acute myelogenous leukemia?, Expert Opinion on Therapeutic Targets, 2014, 18, 8, 929

    CrossRef

  13. 13
    Anne S. Roug, Hanne Ø. Larsen, Line Nederby, Tom Just, Gordon Brown, Charlotte G. Nyvold, Hans B. Ommen, Peter Hokland, hMICL and CD123 in combination with a CD45/CD34/CD117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia, British Journal of Haematology, 2014, 164, 2
  14. 14
    Mohammadreza Sharifi, Rasoul Salehi, Yousof Gheisari, Mohammad Kazemi, Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression, Molecular Biology Reports, 2014, 41, 5, 2799

    CrossRef

  15. 15
    Corrado Girmenia, Alessandra Micozzi, Alfonso Piciocchi, Giuseppe Gentile, Luigi Di Caprio, Daniela Nasso, Clara Minotti, Saveria Capria, Claudio Cartoni, Giuliana Alimena, Giovanna Meloni, Sergio Amadori, Robin Foà, Adriano Venditti, Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia, Leukemia Research, 2014, 38, 4, 469

    CrossRef

  16. 16
    Preetesh Jain, Hagop Kantarjian, Keyur Patel, Stefan Faderl, Guillermo Garcia-Manero, Ohad Benjamini, Gautam Borthakur, Naveen Pemmaraju, Tapan Kadia, Naval Daver, Aziz Nazha, Raja Luthra, Sherry Pierce, Jorge Cortes, Farhad Ravandi, MutatedNPM1in patients with acute myeloid leukemia in remission and relapse, Leukemia & Lymphoma, 2014, 55, 6, 1337

    CrossRef

  17. 17
    Ali Al-Ameri, Ankit Anand, Mohamed Abdelfatah, Zeyad Kanaan, Tracy Hammonds, Nairmeen Haller, Mohamad Cherry, Outcome of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome According to Health Insurance Status, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 6, 509

    CrossRef

  18. 18
    Long-long Liu, Dong-hua Zhang, Xia Mao, Xin-hua Zhang, Bing Zhang, Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia, Biochemical and Biophysical Research Communications, 2014, 446, 1, 280

    CrossRef

  19. 19
    Yonghua Li, Wenning Xu, Zujun Jiang, Yang Gao, Yan Pang, Li Li, Ling OuYang, Leqing Zhang, Zenghui Liu, Yang Wang, Yang Xiao, Xiaojun Huang, RETRACTED ARTICLE: Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China, Tumor Biology, 2014, 35, 6, 5869

    CrossRef

  20. 20
    Dietmar Puchberger-Enengl, Christian Krutzler, Franz Keplinger, Michael J. Vellekoop, Single-step design of hydrogel-based microfluidic assays for rapid diagnostics, Lab Chip, 2014, 14, 2, 378

    CrossRef

  21. 21
    Guillaume Bossis, Jean-Emmanuel Sarry, Chamseddine Kifagi, Marko Ristic, Estelle Saland, François Vergez, Tamara Salem, Héléna Boutzen, Hayeon Baik, Frédérique Brockly, Mireia Pelegrin, Tony Kaoma, Laurent Vallar, Christian Récher, Stéphane Manenti, Marc Piechaczyk, The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs, Cell Reports, 2014, 7, 6, 1815

    CrossRef

  22. 22
    Tsila Zuckerman, Jacob M. Rowe, Transplantation in Acute Myeloid Leukemia, Hematology/Oncology Clinics of North America, 2014, 28, 6, 983

    CrossRef

  23. 23
    Susan K. Rathe, Branden S. Moriarity, Christopher B. Stoltenberg, Morito Kurata, Natalie K. Aumann, Eric P. Rahrmann, Natashay J. Bailey, Ellen G. Melrose, Dominic A. Beckmann, Chase R. Liska, David A. Largaespada, Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia, Scientific Reports, 2014, 4,

    CrossRef

  24. 24
    Ota Fuchs, Cancer Biomarkers, 2014,

    CrossRef

  25. 25
    Elihu H. Estey, Acute myeloid leukemia: 2013 update on risk-stratification and management, American Journal of Hematology, 2013, 88, 4
  26. 26
    Richard J. Lin, Richard A. Larson, Koen van Besien, Elizabeth S. Rich, Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation, Case Reports in Hematology, 2013, 2013, 1

    CrossRef

  27. 27
    Dominik Schneidawind, Birgit Federmann, Christoph Faul, Wichard Vogel, Lothar Kanz, Wolfgang Andreas Bethge, Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia, Annals of Hematology, 2013, 92, 10, 1389

    CrossRef

  28. 28
    Charlotte K. Brierley, Elizabeth A. Morgan, Julian R. Sprague, Oreofe O. Odejide, Daniel J. DeAngelo, David P. Steensma, An extreme example of focal bone marrow involvement in acute myeloid leukemia, American Journal of Hematology, 2013, 88, 4
  29. 29
    Nataliya Mar, Maria A. Gorgan, Mark E. Dailey, James J. Vredenburgh, Blue toes and a new pair of shoes—Challenges in diagnosis and treatment of acute myelogenous leukemia, American Journal of Hematology, 2013, 88, 12
  30. 30
    Reem Alsolami, Samantha JL Knight, Anna Schuh, Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?, Personalized Medicine, 2013, 10, 4, 361

    CrossRef

  31. 31
    Beatriz Sanchez-Correa, Juan M. Bergua, Carmen Campos, Inmaculada Gayoso, Maria Jose Arcos, Helena Bañas, Sara Morgado, Javier G. Casado, Rafael Solana, Raquel Tarazona, Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels, Cytokine, 2013, 61, 3, 885

    CrossRef

  32. 32
    Ingrid Jakobsen Falk, Anna Fyrberg, Esbjörn Paul, Hareth Nahi, Monica Hermanson, Richard Rosenquist, Martin Höglund, Lars Palmqvist, Dick Stockelberg, Yuan Wei, Henrik Gréen, Kourosh Lotfi, Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5′-nucleotidase, American Journal of Hematology, 2013, 88, 12
  33. 33
    David H. Spencer, Haley J. Abel, Christina M. Lockwood, Jacqueline E. Payton, Philippe Szankasi, Todd W. Kelley, Shashikant Kulkarni, John D. Pfeifer, Eric J. Duncavage, Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data, The Journal of Molecular Diagnostics, 2013, 15, 1, 81

    CrossRef

  34. 34
    G. Lu, R. A. Schulz, C. E. Bueso-Ramos, J. E. Cortes, X. Iris Wang, L. J. Medeiros, C. C. Yin, Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemia, Journal of Clinical Pathology, 2013, 66, 9, 826

    CrossRef

  35. 35
    Naval Daver, Theresa Liu Dumlao, Farhad Ravandi, Sherry Pierce, Gautam Borthakur, Naveen Pemmaraju, Aziz Nazha, Stefan Faderl, Elias Jabbour, Guillermo Garcia-Manero, Jorges Cortes, Hagop Kantarjian, Alfonso Quintás-Cardama, Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 4, 435

    CrossRef

  36. 36
    Ø. Bruserud, K. Liseth, S. Stamnesfet, D. L. Cacic, G. Melve, E. Kristoffersen, T. Hervig, H. Reikvam, Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia, Transfusion Medicine, 2013, 23, 6
  37. 37
    Pengcheng Shi, Jie Zha, Xutao Guo, Feili Chen, Zhiping Fan, Fen Huang, Fanyi Meng, Xiaoli Liu, Ru Feng, Bing Xu, Idarubicin is superior to daunorubicin in remission induction ofde novoacute myeloid leukemia patients with highMDR1expression, Pharmacogenomics, 2013, 14, 1, 17

    CrossRef

  38. 38
    Roberto Castelli, Ramona Cassin, Antonino Cannavò, Massimo Cugno, Immunomodulatory Drugs: New Options for the Treatment of Myelodysplastic Syndromes, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 1, 1

    CrossRef

  39. 39
    Anna Martner, Fredrik Bergh Thorén, Johan Aurelius, Kristoffer Hellstrand, Immunotherapeutic strategies for relapse control in acute myeloid leukemia, Blood Reviews, 2013, 27, 5, 209

    CrossRef

  40. 40
    Håkon Reikvam, Ina Nepstad, André Sulen, Bjørn Tore Gjertsen, Kimberley Joanne Hatfield, Øystein Bruserud, Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors, Expert Opinion on Investigational Drugs, 2013, 22, 5, 551

    CrossRef

  41. 41
    Katsuya Yamamoto, Atsuo Okamura, Yukinari Sanada, Kimikazu Yakushijin, Hiroshi Matsuoka, Hironobu Minami, Micronuclei-associated MYC amplification in the form of double minute chromosomes in acute myeloid leukemia, American Journal of Hematology, 2013, 88, 8
  42. 42
    Mareike Rickmann, Laura Macke, Bala Sai Sundarasetty, Kathrin Stamer, Constanca Figueiredo, Rainer Blasczyk, Michael Heuser, Juergen Krauter, Arnold Ganser, Renata Stripecke, Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia, Annals of Hematology, 2013, 92, 8, 1079

    CrossRef

  43. 43
    Heesun J. Rogers, Eric D. Hsi, Myeloid Neoplasms with inv(3)(q21q26.2) or t(3;3)(q21;q26.2), Surgical Pathology Clinics, 2013, 6, 4, 677

    CrossRef

  44. 44
    Nico Lachmann, Sebastian Brennig, Ruhi Phaltane, Michael Flasshove, Dagmar Dilloo, Thomas Moritz, Myeloprotection by Cytidine Deaminase Gene Transfer in Antileukemic Therapy, Neoplasia, 2013, 15, 3, 239

    CrossRef

  45. 45
    Elise Boudry-Labis, Catherine Roche-Lestienne, Olivier Nibourel, Nicolas Boissel, Christine Terre, Christine Perot, Virginie Eclache, Nathalie Gachard, Isabelle Tigaud, Ghislaine Plessis, Wendy Cuccuini, Sandrine Geffroy, Céline Villenet, Martin Figeac, Frederic Leprêtre, Aline Renneville, Meyling Cheok, Jean Soulier, Hervé Dombret, Claude Preudhomme, Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia, American Journal of Hematology, 2013, 88, 4
  46. 46
    Hanne Fredly, Elisabeth Ersvær, Astrid Kittang, Galina Tsykunova, Bjørn Gjertsen, Øystein Bruserud, The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia, Clinical Epigenetics, 2013, 5, 1, 13

    CrossRef

  47. 47
    Ruben A. Mesa, The evolving treatment paradigm in myelofibrosis, Leukemia & Lymphoma, 2013, 54, 2, 242

    CrossRef

  48. 48
    Jason N. Barreto, Cassidy L. Beach, Robert C. Wolf, Julianna A. Merten, Pritish K. Tosh, John W. Wilson, William J. Hogan, Mark R. Litzow, The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole, American Journal of Hematology, 2013, 88, 4
  49. 49
    S. J. Forman, J. M. Rowe, The myth of the second remission of acute leukemia in the adult, Blood, 2013, 121, 7, 1077

    CrossRef

  50. 50
    A. Quintas-Cardama, F. Ravandi, T. Liu-Dumlao, M. Brandt, S. Faderl, S. Pierce, G. Borthakur, G. Garcia-Manero, J. Cortes, H. Kantarjian, Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia, Blood, 2012, 120, 24, 4840

    CrossRef

  51. You have free access to this content51
    Annet Simons, Birgit Sikkema-Raddatz, Nicole de Leeuw, Nicole Claudia Konrad, Rosalind J. Hastings, Jacqueline Schoumans, Genome-wide arrays in routine diagnostics of hematological malignancies, Human Mutation, 2012, 33, 6
  52. 52
    Anita Ryningen, Håkon Reikvam, Ina Nepstad, Kristin Paulsen Rye, Øystein Bruserud, Inhibition of Mammalian Target of Rapamycin in Human Acute Myeloid Leukemia Cells Has Diverse Effects That Depend on the Environmental In Vitro Stress, Bone Marrow Research, 2012, 2012, 1

    CrossRef

  53. 53
    Jane Liesveld, Management of AML: Who do we really cure?, Leukemia Research, 2012, 36, 12, 1475

    CrossRef

  54. 54
    Gerald B. W. Wertheim, Elizabeth Hexner, Adam Bagg, Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy, Molecular Diagnosis & Therapy, 2012, 16, 6, 357

    CrossRef

  55. 55
    Chang Dong Yeo, Jin Woo Kim, Seok Chan Kim, Young Kyoon Kim, Kwan Hyoung Kim, Hee Je Kim, Seok Lee, Chin Kook Rhee, Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit, Journal of Critical Care, 2012, 27, 6, 739.e1

    CrossRef

  56. 56
    Kelly W. Maloney, Roger Giller, Stephen P. Hunger, Recent Advances in the Understanding and Treatment of Pediatric Leukemias, Advances in Pediatrics, 2012, 59, 1, 329

    CrossRef

  57. 57
    Romain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, Odile Blanchet, Arnaud Pigneux, Christian Recher, Caroline Bonmati, Nathalie Fegueux, Claude-Eric Bulabois, Didier Bouscary, Norbert Vey, Martine Delain, Pascal Turlure, Chantal Himberlin, Jean-Luc Harousseau, Francois Dreyfus, Marie C. Béné, Norbert Ifrah, Patrice Chevallier, Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study, American Journal of Hematology, 2012, 87, 12
  58. 58
    Yao Guo, Yun Chen, Xuesong Xu, Xueqi Fu, Zhizhuang Zhao, SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells, Journal of Hematology & Oncology, 2012, 5, 1, 72

    CrossRef

  59. 59
    Ashkan Emadi, Judith E Karp, The clinically relevant pharmacogenomic changes in acute myelogenous leukemia, Pharmacogenomics, 2012, 13, 11, 1257

    CrossRef

  60. 60
    Frédéric Peyrade, Lauris Gastaud, Daniel Ré, Sandrine Pacquelet-Cheli, Antoine Thyss, Treatment decisions for elderly patients with haematological malignancies: a dilemma, The Lancet Oncology, 2012, 13, 8, e344

    CrossRef